Characteristic | MIT group (n= 55) | CIT group (n= 57) | P value |
---|---|---|---|
Primary ICU admitting diagnosis | Â | Â | Â |
   Sepsis | 25 | 26 |  |
   Respiratory | 11 | 12 |  |
   Neurologic | 9 | 7 |  |
   Cardiovascular | 3 | 5 |  |
   Gastrointestinal or liver | 2 | 3 |  |
   Hematologic or oncologic | 3 | 1 |  |
   Renal | 1 | 2 |  |
   Metabolic | 1 | 1 |  |
Age | 68.1 ± 16.3 | 70.4 ± 12.1 | 0.40 |
Body weight (kg) | 61.4 ± 9.6 | 62.5 ± 9.8 | 0.57 |
Gender (female/male) | 16/39 (41%) | 16/41 (39%) | 0.90 |
Body mass index (kg/m2) | 23.6 ± 3.0 | 23.9 ± 3.8 | 0.72 |
History of diabetes | 19/55 (34.5%) | 22/57 (38.6%) | 0.67 |
Previous corticosteroid treatment | 14/55 (25.4%) | 16/57 (28.1%) | 0.77 |
Use of inotropes | 15/55 (27.3) | 12/57 (21.1) | 0.44 |
APACHE II score | 20 (17 to 25) | 21 (16.5 to 26.5) | 0.94 |
Patients with total parenteral nutrition | 2/55 (3.6%) | 2/57 (3.5%) | 0.97 |
Intake of nutrients | Â | Â | Â |
   Carbohydrate (%) | 54.3 ± 0.2 | 54.4 ± 0.2 | 0.84 |
   Protein (%) | 16.4 ± 0.1 | 16.4 ± 0.2 | 0.50 |
   Fat (%) | 29.3 ± 0.2 | 29.2 ± 0.8 | 0.55 |
At randomization | Â | Â | Â |
   Blood glucose (mg/dl) | 229.2 ± 39.3 | 231.1 ± 52.1 | 0.93 |
   Serum hemoglobin (g/dl) | 10.9 ± 2.2 | 10.8 ± 2.3 | 0.80 |
   Serum ALT (U/l) | 59.1 ± 79.3 | 63.8 ± 83.0 | 0.76 |
   Serum total bilirubin (mg/dl) | 1.1 ± 0.4 | 1.2 ± 0.4 | 0.88 |
   UUN (g/BSA/24 hours) | 7.0 ± 3.7 | 6.7 ± 3.8 | 0.78 |
   Nitrogen balance (g/BSA/day) | -4.8 ± 5.9 | -4.7 ± 4.5 | 0.93 |
   Serum albumin (mg/dl) | 1,949.9 ± 376.0 | 1,955.4 ± 506.5 | 0.95 |
   Serum prealbumin (mg/dl) | 11.3 ± 5.2 | 11.2 ± 4.5 | 0.87 |